Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=5597956

Clinical pharmacology of lacidipine. Discussion

Author
HALL, S. T1 ; HARDING, S. M; EVANS, G. L; PELLEGATTI, M; RIZZINI, P; LEONETTI (Commentator) ; HALL (Commentator)
[1] Glaxo Group Research, dep. clin. pharmacology, Greenford Middx. UB6 0HE, United Kingdom
Source

Journal of cardiovascular pharmacology. 1991, Vol 17, pp S9-S13 ; SUP4 ; ref : 18 ref

CODEN
JCPCDT
ISSN
0160-2446
Scientific domain
Cardiology, blood circulation, phlebology; Pharmacology drugs
Publisher
Lippincott, Hagerstown, MD / Lippincott, Philadelphia, PA
Publication country
United States
Document type
Article
Language
English
Keyword (fr)
Antagoniste calcium Antihypertenseur Electrophysiologie Essai clinique phase I Homme Hémodynamique Lacidipine Pharmacocinétique Toxicité Voie orale Dihydropyridine dérivé
Keyword (en)
Calcium antagonist Antihypertensive agent Electrophysiology Phase I trial Human Hemodynamics Pharmacokinetics Toxicity Oral administration Dihydropyridine derivative
Keyword (es)
Antagonista calcio Antihipertensivo Electrofisiología Ensayo clínico fase I Hombre Hemodinámica Farmacocinética Toxicidad Vía oral
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02F Cardiovascular system / 002B02F05 Antihypertensive agents

Discipline
Pharmacological treatments
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
5597956

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web